Ovodan Biotech A/S: Financial statements 2024
CVR: 33870256
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Ovodan Biotech A/S (CVR 33870256) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -312,560 and a net result of DKK -1,177,651 compared with DKK 220,846 the year before. Equity in the 2024 report amounted to DKK 316,499. The solvency ratio was 21.8%. The company had 2 employees in the financial year.
- Gross Profit
- DKK -312,560
- Profit/Loss
- DKK -1,177,651
- Equity
- DKK 316,499
- Total Assets
- DKK 1,448,514
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -313K | -1.2M | 316K | 2 |
| 2023 | - | -157K | 221K | -20.5M | 2 |
| 2022 | - | -439K | -1.5M | -20.7M | 3 |
| 2021 | - | -741K | -2M | -19.2M | 3 |
| 2020 | - | -1.5M | -3.1M | -17.2M | 5 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of July 1, 2024, Ovodan Foods A/S is registered as an owner of Ovodan Biotech A/S with an ownership share of 100%.
Ovodan Biotech A/S has published its annual report for 2023. Gross profit came to DKK -157,221, and the net result was DKK 220,846.
About Ovodan Biotech A/S
Ovodan Biotech A/S is a Danish company of the type Aktieselskab based in Odense C, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SANOVO BIOTECH A/S. The management consists of Henrik Marinus Pedersen. The board consists of Thor Stadil (chair), Christian Nicholas Rosenkrantz Stadil and Henrik Marinus Pedersen. The company is owned by Ovodan Foods A/S. The company has 0 employees (2012). In 2025, the company reported a gross profit of DKK -805,830 and a net result of DKK -1,201,387 compared with DKK -1,177,651 the year before. Equity in the 2025 report amounted to DKK -884,888.